Loading clinical trials...
Loading clinical trials...
GraftAssureDx Study: Validation of Donor-Derived Cell-Free DNA (Dd-cfDNA) for Kidney Transplant Monitoring
Conditions
Interventions
donor-derived cell-free DNA test
Locations
10
United States
University of Southern California Keck School of Medicine
Los Angeles, California, United States
Mayo Clinic in Florida
Jacksonville, Florida, United States
Tampa General Hospital
Tampa, Florida, United States
Cleveland Clinic
Cleveland, Ohio, United States
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States
Vanderbilt University Medical Center
Nashville, Tennessee, United States
Start Date
September 8, 2025
Primary Completion Date
November 30, 2025
Completion Date
December 1, 2025
Last Updated
November 19, 2025
NCT07412470
NCT07415876
NCT07006532
NCT07006831
NCT07275541
NCT04736381
Lead Sponsor
Insight Molecular Diagnostics
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions